人肝癌组织中nm23-H1基因表达及其cDNA基因突变的研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
目的 检测肿瘤转移抑制基因nm23-H1在原发性肝细胞癌(hepatocellular carcinoma,HCC)中的表达及其基因突变情况,探讨nm23-H1在HCC发生发展中的作用及肝癌细胞转移的分子生物学机制。方法 应用半定量逆转录聚合酶链反应(RT-PCR)技术及单链构象多态法(single strand conformation polymorphism,SSCP),对30例肝癌组织、30例癌旁组织和16例正常肝组织中nm23-H1基因的表达情况及cDNA基因突变情况进行检测和分析。结果 30例肝癌患者的癌组织、相应癌旁组织及正常组织中nm23-H1基因阳性表达率均为100%,nm23-H1基因阳性表达率在这三者之间无差异;②nm23-H1基因在肝癌组织、癌旁组织、正常组织中的表达水平分别为1.619±0.407((?)±s)、1.302±0.304((?)±s)及1.232±0.386((?)±s)。统计学分析表明在这三种组织中nm23-H1基因的表达水平有显著差异(P<0.01)。肝癌组织中nm23-H1基因的表达水平明显低于癌旁组织(P<0.05)和正常组织(P<0.01)。该基因在癌旁组织和正常组织中的表达水平无显著差异(P>0.05);③低分化肝癌组织中nm23-H1基因表达水平低于高、中分化肝癌组织中nm23-H1基因表达水平(P<0.05);④有卫星转移灶的和无卫星灶的肝癌组织中nm23-H1基因表达水平无显著差异(P>0.05);⑤肝癌组织中nm23-H1基因表达水平与患者的年龄、性别无显著相关性(P值均大于0.05);⑥30例肝癌组织及相应的癌旁组织中未发现1例存在nm23-H1 cDNA基因突变。结论 ①原发性肝细胞癌中nm23-H1基因阴性表达率很低;②nm23-H1基因在肝癌组织中的表达水平明显低于癌旁组织和正常组织,提示nm23-H1失活与肝癌发生相关;③原发性肝细胞癌中nm23-H1表达水平与肝癌恶性程度有明显相关性,提示nm23-H1变异可以作为患者预后的指标;④肝癌组织中nm23-H1表达水平与卫星转移灶的有无及患者的性别、年龄均无明显相关性;⑤肝癌组织及癌旁组织中nm23-H1 cDNA基因突变率很低。
Objective To detect the expression of nm23-H1 and its cDNA gene mutation in hepatocellular carcinoma (HCC), and study the role of nm23-H1 in the pathogenesis of HCC and elucidate the molecular biology mechanism of hepatocellular carcinoma metastasis. Methods Using semi-quantitive reverse transcriptase-polymerase chain reaction (RT-PCR) and single strand conformation polymorphism (SSCP) , the expression variation and cDNA gene mutation of nm23-Hl gene were detected in 30 HCC tissues, their corresponding adjacent liver tissues and in normal liver tissues of 16 non-liver disease patients. Results 漏the expression rate of nm23-Hl RNA was 100% in the HCC tissues , their corresponding adjacent tissues and in the normal liver tissues. There were no significant difference in the expression rate of nm23-H1 gene among the three kind of tissues(P>0. 05); (2)The expression level of nm23-Hl gene in the HCC tissues, their adjacent tissues and normal liver tissues was 1.619 0.407( x s), 1.302 0.343( x s) and 1.232 0.386(
     x s), respectively. The expression level of nm23-H1 gene in the HCC tissues was singnificantly lower than that in the adjacent and normal liver tissues (P <0.01); (3) The expression level of nm23-H1 gene in the low-differentiated HCC was much lower than that in the high and middle differentiated HCC tissues (P< 0.01); (4) The expression level of nm23-Hl gene in HCC tissues with satellite focuses was not significantly different from that without satellite focuses (P > 0. 05) ; (5) The expression quantity of nm23-H1 gene in HCC tissues was not closely related to HCC patients' age and gender (P>0. 05) ; (6) None of the nm23-Hl gene mutation was found in all the hepatocellular carcinoma samples. Conclusion (1)The negative expression rate of nm23-H1 in the HCC tissues is very low; (2) The expression level of nm23-H1 in the HCC tissues is much lower than that in the adjacent and normal liver tissues, which indicates that the inactivation of nm23-H1 is associated with the
    
    
    pathogenesis of HCC; (3)The expression level of nm23-Hl gene is highly associated with the pathological differentiation of HCC, which indicates that the alternation of nm23-Hl can serve as a prognostic indicators in the progression of HCC; (4)The expression level of nm23-Hl gene in HCC tissues was not closely related to HCC patients' age, gender and whether there are satellite focuses in HCC tissues; (5) The cDNA gene mutation rate of nm23-Hl in the HCC tissues is very low.
引文
1 易基群,杨晓明,曾波航,等.肿瘤转移抑制基因nm23-H1 mRNA在乳腺癌中的转录表达.现代临床医学生物工程学杂志,2003,9(2):85-87
    2 Aoyagi K, Koufuji K, Kodama I. Immunohistochemical analysis of erbB-2 and nm23 expression in gastric carcinoma. Nippon Shokakibyo Gakkai Zasshi ,1996, (9):613-619
    3 Iizuka N, Tangoku A, Hazama S, et al. nm23-H1 gene as a molecular switch between the free floating and adherent states of gastric cancer cells. Cancer Lett, 2001, 1:651-671
    4 Iizuka N, Tangoku A, Hayashi H, et al. The association between nm23-H1 expression and survival in patients with esophageal squamous cell carcinoma. Cancer Lett, 1999,12:139-144
    5 杨毅军,曹道俊,许菊萍,等.青年人大肠癌nm23基因表达及意义.河南肿瘤杂志,2000,13(2):87-88
    6 Volm M, Mattern J, Koomgi R. Association between nm23-H1 expression ,proliferation and apotosis in non-small cell lung carcinoma. Clin Exp metastasis, 1998,16(7):595-602
    7 陈琼,陈合群,李国虎.原发性肺癌nm23基因mRNA表达的研究.中国现代医学杂志,2001,11(4):18-21
    8 王忠民,常德安.上皮性卵巢癌中nm23-H1基因突变.肿瘤,2002,22(3):209-212
    9 吕志勇,吕怀盛,陈福宝,等.nm23-H1基因产物在膀胱移行细胞癌的表达及临床意义.宁夏医学杂志,2002,24(5):259-261
    10 孔宪国,张元芳,丁强,等.肾癌nm23-H1 mRNA表达与浸润转移的关系.中华肿瘤杂志,2000,19:88
    11 Shimada M, Taguchi K, Hasegawa H. nm23-H1 expression in intrahepatic or extrahepatic metastases of hepatocellular carcinoma. Liver, 1998,5:337-342
    12 Lin LI, Lee PH, Wu CM. Significance of nm23 mRNA expression in human hepatocellular carcinoma. Anticancer Res, 1998,1B:541-546
    13 赵爱志,窦羽峰,李开宗,等.肝细胞癌中血管内皮生长因子及nm23-H1蛋白的表达.第四军医大学学报,2000,21(11):136-137
    14 马文峰,翟秀岩,长崛熏,等.抗转移基因nm23-H1在多发性肝癌中的表达.中国医
    
    科大学学报,2001,30(6):421-422
    15 Matthias Engel, Birgit Theisinger, Thomas Seib, et al. High levels of nm23-H1 and nm23-H2 messenger RNA in human squamous-cell lung carcinoma are associated with poor differentiation and advanced tumor stages. Int. J. Cancer, 1993,55:373-379
    16 Steeg PS, Bevilacqua, Kopper L, et al. Evidence for a novel gene associated with low tumor metastatic potential. J. Natl. Cancer Inst, 1988, 80:200
    17 Biggs J, Hersperger E, Steeg PS, et al. A droscphila gene that is homologous to a mammalian gene associated tumor metastasis codes for a nucleoside diphosphate kinase. Cell, 1990, 63:933
    18 Steeg PS, Bevilacqua G, Pozzatti R, et al. Alteres expression of nm23 a gene associated with low tumor metastatic potential, during adenovirus Z Ela inhibition of experimental metastasis. Cancer Res, 1988,48(22):6550-6554
    19 Leone A, Flatow U, King C, et al. Reduced tumor incidence metastatic potential and cytokine responsiveness of nm23 transfected melanoma cells. Cell, 1991,65(1):25-35
    20 Leone A, Flatow U, Van Houtte K, et al. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: relationship to growth colonization metastatic potential and enzymatic activity. Cancer, 1994,79(12):2913-2922
    21 Price JE, Polyzos A, Zhang RD, et al. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res, 1990, 50 (3) : 717-721
    22 Fujimoto Y, Ohtake T, Nishimori H. Reduced expression and rare genomic altern of nm23-H1 in human hepatocellular carcinoma and hepatoma cell lines. J Gastroenterol, 1998,3:368-375
    23 Boix L, Bruix J, Campo E, et al. nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma. Gastroenterology, 1994,107(2): 486-491
    24 Zheng XY, Ling ZY, Tang ZY. The abundance of nm23-H1 mRNA is related with in situ microenvironment and intrahepatic metastasis in hepatocellular carcinoma. J Exp Clin Cancer Res, 1998,3:337-341
    
    
    25 Chen X, Dai Y, Yang J. Expression of metastasis suppressor gene nm23 in human hepatocellular carcinoma. Chung Hua Ping Li Hsueh Tsa Chih, 1996,2:76-78
    26 Leone A, McBride OW, Weston A, et al. Somatic allelic deletion of nm23 in human cancer. Cancer Res, 1991,51(9):2490-2493
    27 Cohn KH, Wang FS, Desoto-Lapaix F, et al. Association of nm23-H1 allelic deletions with distant metastasis in colorectal carcinoma. Lancet, 1991, 238(8769): 722-724
    28 黄培林,金月玲,黄照权,等.nm23-H1基因突变及异常表达与大肠癌转移相关性的研究.东南大学学报(医学版),2002,21(1):44-48
    29 Leone A, Seeger RC, Hong CM, et al. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene, 1993,8(4):855-865
    30 陈军,周清华,覃扬,等.人肺癌中nm23等位基因缺失的研究.中国肺癌杂志,2000,3(1):8-13
    31 于景翠,李晓敏,傅松滨.肺癌基因组nm23-H1基因的扩增及异常分析.哈尔滨医科大学学报,2000,34(1):6-7
    32 王国丽,杜传书,林群娣.非小细胞肺癌淋巴结转移与nm23-H1基因突变及mRNA表达异常关系研究.中国结核和呼吸杂志,1997,20(6):340-343
    33 王国丽,杜传书.人原发性乳腺癌及肺癌中乳腺癌抑制基因突变.中山医科大学学报,1996,17:95
    34 刘伦旭,周清华,石应康,等.人肺癌组织中nm23-H1基因突变研究.中国肺癌杂志,2000,3(3):313-317

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700